WNT pathway alterations also frequently occur in other gastric cancer subtypes, with 78% of cases most prominently in the MSI subtype, which also contains TP53 pathway alterations in 77% of cases (The Cancer Genome Atlas Research Network, 2014). This evidence concerns the gene TP53 and gastric cancer.